What is the ROE (Return on Equity) of Zeria Pharmaceutical Co this year?
The ROE of Zeria Pharmaceutical Co this year is 0.1 undefined.
In 2024, Zeria Pharmaceutical Co's return on equity (ROE) was 0.1, a 34.56% increase from the 0.07 ROE in the previous year.
Zeria Pharmaceutical Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Analyzing Zeria Pharmaceutical Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Zeria Pharmaceutical Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Changes in Zeria Pharmaceutical Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
The ROE of Zeria Pharmaceutical Co this year is 0.1 undefined.
The ROE of Zeria Pharmaceutical Co has increased by 34.56% increased compared to the previous year.
A high ROE indicates that Zeria Pharmaceutical Co generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
A low ROE can indicate that Zeria Pharmaceutical Co is having difficulties monetizing its investments successfully and can be a negative signal for investors.
A change in ROE (Return on Equity) of Zeria Pharmaceutical Co can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Some factors that can influence Zeria Pharmaceutical Co's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
Over the past 12 months, Zeria Pharmaceutical Co paid a dividend of 45 JPY . This corresponds to a dividend yield of about 1.99 %. For the coming 12 months, Zeria Pharmaceutical Co is expected to pay a dividend of 46.78 JPY.
The current dividend yield of Zeria Pharmaceutical Co is 1.99 %.
Zeria Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
Zeria Pharmaceutical Co paid dividends every year for the past 23 years.
For the upcoming 12 months, dividends amounting to 46.78 JPY are expected. This corresponds to a dividend yield of 2.07 %.
Zeria Pharmaceutical Co is assigned to the 'Health' sector.
To receive the latest dividend of Zeria Pharmaceutical Co from 12/1/2024 amounting to 23 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
The last dividend was paid out on 12/1/2024.
In the year 2023, Zeria Pharmaceutical Co distributed 44 JPY as dividends.
The dividends of Zeria Pharmaceutical Co are distributed in JPY.
Our stock analysis for Zeria Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zeria Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.